Editorial: Tumor-associated antigens and their autoantibodies, from discovering to clinical utilization

doi:10.3389/fonc.2022.970623

Editorial

. 2022 Jul 20:12:970623.

doi: 10.3389/fonc.2022.970623. eCollection 2022.

Editorial: Tumor-associated antigens and their autoantibodies, from discovering to clinical utilization

Jianying Zhang¹, Xiangqian Guo², Bilian Jin³, Qing Zhu⁴

Affiliations

¹ Department of Biological Sciences, The University of Texas at El Paso, El Paso, TX, United States.
² Department of Preventive Medicine, Institute of Biomedical Informatics, Bioinformatics Center, Henan Provincial Engineering Center for Tumor Molecular Medicine, School of Basic Medical Sciences, Academy for Advanced Interdisciplinary Studies, Henan University, Kaifeng, China.
³ Cancer Center, Dalian Medical University, Dalian, China.
⁴ West China Hospital, Sichuan University, Chengdu, China.

PMID: 35936692
PMCID: PMC9346231
DOI: 10.3389/fonc.2022.970623

Editorial

Editorial: Tumor-associated antigens and their autoantibodies, from discovering to clinical utilization

Jianying Zhang et al. Front Oncol. 2022.

. 2022 Jul 20:12:970623.

doi: 10.3389/fonc.2022.970623. eCollection 2022.

Authors

Jianying Zhang¹, Xiangqian Guo², Bilian Jin³, Qing Zhu⁴

Affiliations

¹ Department of Biological Sciences, The University of Texas at El Paso, El Paso, TX, United States.
² Department of Preventive Medicine, Institute of Biomedical Informatics, Bioinformatics Center, Henan Provincial Engineering Center for Tumor Molecular Medicine, School of Basic Medical Sciences, Academy for Advanced Interdisciplinary Studies, Henan University, Kaifeng, China.
³ Cancer Center, Dalian Medical University, Dalian, China.
⁴ West China Hospital, Sichuan University, Chengdu, China.

PMID: 35936692
PMCID: PMC9346231
DOI: 10.3389/fonc.2022.970623

No abstract available

Keywords: autoantibody; biomarker; cancer; immunodiagnosis; tumor-associated antigen.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

Editorial on the Research Topic Tumor-Associated Antigens and Their Autoantibodies: From Discovering to Clinical Utilization

Cited by

From Basic Science to Clinical Practice: The Role of Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A)/p90 in Cancer.
Chen B, Hu H, Chen X. Chen B, et al. Front Genet. 2023 Feb 24;14:1110656. doi: 10.3389/fgene.2023.1110656. eCollection 2023. Front Genet. 2023. PMID: 36911405 Free PMC article. Review.

References

1. Tan EM, Zhang JY. Autoantibodies to tumor-associated antigens: reporters from the immune system. Immunol Rev (2008) 222:328–40. doi: 10.1111/j.1600-065X.2008.00611.x - DOI - PMC - PubMed
1. Zhang JY, Tan EM. Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors. Expert Rev Mol Diagn (2010) 10(3):321–8. doi: 10.1586/erm.10.12 - DOI - PMC - PubMed
1. Lubin R, Zalcman G, Bouchet L, Tredaniel J, Legros Y, Cazals D, et al. . Serum p53 antibodies as early markers of lung cancer. Nat Med (1995) 1(7):701–2. doi: 10.1038/nm0795-701 - DOI - PubMed
1. Soussi T. p53 antibodies in the sera of patients with various types of cancer: A review. Cancer Res (2000) 60(7):1777–88. - PubMed
1. Zhang JY, Casiano CA, Peng XX, Koziol JA, Chan EKL, Tan EM. Enhancement ot antibody detection in cancer using panel of recombinant tumor-associated antigens. Cancer Epidemiol Biomarkers Prev (2003) 12(2):136–43. - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources

[1] Tan EM, Zhang JY. Autoantibodies to tumor-associated antigens: reporters from the immune system. Immunol Rev (2008) 222:328–40. doi: 10.1111/j.1600-065X.2008.00611.x - DOI - PMC - PubMed

[2] Tan EM, Zhang JY. Autoantibodies to tumor-associated antigens: reporters from the immune system. Immunol Rev (2008) 222:328–40. doi: 10.1111/j.1600-065X.2008.00611.x - DOI - PMC - PubMed

[3] Zhang JY, Tan EM. Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors. Expert Rev Mol Diagn (2010) 10(3):321–8. doi: 10.1586/erm.10.12 - DOI - PMC - PubMed

[4] Zhang JY, Tan EM. Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors. Expert Rev Mol Diagn (2010) 10(3):321–8. doi: 10.1586/erm.10.12 - DOI - PMC - PubMed

[5] Lubin R, Zalcman G, Bouchet L, Tredaniel J, Legros Y, Cazals D, et al. . Serum p53 antibodies as early markers of lung cancer. Nat Med (1995) 1(7):701–2. doi: 10.1038/nm0795-701 - DOI - PubMed

[6] Lubin R, Zalcman G, Bouchet L, Tredaniel J, Legros Y, Cazals D, et al. . Serum p53 antibodies as early markers of lung cancer. Nat Med (1995) 1(7):701–2. doi: 10.1038/nm0795-701 - DOI - PubMed

[7] Soussi T. p53 antibodies in the sera of patients with various types of cancer: A review. Cancer Res (2000) 60(7):1777–88. - PubMed

[8] Soussi T. p53 antibodies in the sera of patients with various types of cancer: A review. Cancer Res (2000) 60(7):1777–88. - PubMed

[9] Zhang JY, Casiano CA, Peng XX, Koziol JA, Chan EKL, Tan EM. Enhancement ot antibody detection in cancer using panel of recombinant tumor-associated antigens. Cancer Epidemiol Biomarkers Prev (2003) 12(2):136–43. - PubMed

[10] Zhang JY, Casiano CA, Peng XX, Koziol JA, Chan EKL, Tan EM. Enhancement ot antibody detection in cancer using panel of recombinant tumor-associated antigens. Cancer Epidemiol Biomarkers Prev (2003) 12(2):136–43. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Editorial: Tumor-associated antigens and their autoantibodies, from discovering to clinical utilization

Affiliations

Editorial: Tumor-associated antigens and their autoantibodies, from discovering to clinical utilization

Authors

Affiliations

Conflict of interest statement

Comment on

Similar articles

Cited by

References

Publication types

LinkOut - more resources

Full Text Sources